Skip to main content
INGN
NASDAQ Life Sciences

Inogen's Q1 Revenue Jumps 3.4% to Beat Estimates, Driven by International Demand

Tom Rudovsky · Reported by Reuters
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$7.05
Mkt Cap
$196.464M
52W Low
$5.34
52W High
$9.13
52W Position info
32% above low
Off High info
23% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

INGN sits 32% above its 52-week low of $5.34.

Summary

Inogen reported first-quarter revenue of $85.10 million, a 3.4% year-over-year increase, exceeding analyst estimates of $82.35 million. The company also surpassed adjusted net income expectations, reporting -$4 million against a -$7.70 million consensus, primarily driven by strong international demand for its portable oxygen concentrators. While adjusted EBITDA slightly missed estimates at -$1.40 million, the company reiterated its full-year 2026 revenue guidance of $366 million to $373 million and its commitment to improving adjusted EBITDA. This mixed earnings report indicates continued top-line growth, particularly internationally, but highlights ongoing profitability challenges from increased R&D investment. Traders will watch for sustained international growth and progress towards positive adjusted EBITDA throughout the year.

At the time of this announcement, INGN was trading at $7.05 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $196.5M. The 52-week trading range was $5.34 to $9.13. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

INGN - Latest Insights

INGN
Nov 05, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.30
Real-time Price: $5.66 info
Change: -$0.6399 (-10%) info
Market Cap: $179.665M info
INGN
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $6.50
Real-time Price: $5.66 info
Change: -$0.840 (-13%) info
Market Cap: $179.665M info
INGN
Nov 05, 2026, 4:00 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $6.81
Real-time Price: $5.66 info
Change: -$1.14 (-17%) info
Market Cap: $179.665M info
INGN
Sep 30, 2026, 5:26 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.62
Real-time Price: $5.66 info
Change: +$0.040 (+0.71%) info
Market Cap: $179.665M info
INGN
Sep 30, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.27
Real-time Price: $5.66 info
Change: +$0.390 (+7%) info
Market Cap: $179.665M info